Literature DB >> 7075085

Protein binding of some non-steroidal anti-inflammatory drugs in rheumatoid arthritis.

S Wanwimolruk, D J Birkett, P M Brooks.   

Abstract

The protein binding of 4 non-steroidal anti-inflammatory drugs and warfarin was investigated in 10 patients with rheumatoid arthritis and in a matched control group of patients with osteoarthritis. There were no differences between the groups in the free fractions of the 5 drugs studied. Fluorescent probe studies also showed only minor differences between groups. The results do not support previous suggestions that drug protein binding is altered in rheumatoid arthritis. Albumin concentration was positively correlated with the binding of salicylate, but not with binding of the other 4 drugs. Fatty acid concentration was directly correlated with the binding of warfarin and indomethacin. Correlations between drugs with respect to protein binding were investigated, but only that between salicylate and ibuprofen was significant.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7075085     DOI: 10.2165/00003088-198207010-00005

Source DB:  PubMed          Journal:  Clin Pharmacokinet        ISSN: 0312-5963            Impact factor:   6.447


  14 in total

1.  The characterization of two specific drug binding sites on human serum albumin.

Authors:  G Sudlow; D J Birkett; D N Wade
Journal:  Mol Pharmacol       Date:  1975-11       Impact factor: 4.436

2.  Spectroscopic techniques in the study of protein binding. A fluorescence technique for the evaluation of the albumin binding and displacement of warfarin and warfarin-alcohol.

Authors:  G Sudlow; D J Birkett; D N Wade
Journal:  Clin Exp Pharmacol Physiol       Date:  1975 Mar-Apr       Impact factor: 2.557

3.  THE COLORIMETRIC MICRO-DETERMINATION OF NON-ESTERIFIED FATTY ACIDS IN PLASMA.

Authors:  W G DUNCOMBE
Journal:  Clin Chim Acta       Date:  1964-02       Impact factor: 3.786

4.  The displacement of L-tryptophan and dipeptides from bovine albumin in vitro and from human plasma in vivo by antirheumatic drugs.

Authors:  J N McArthur; P D Dawkins; M J Smith
Journal:  J Pharm Pharmacol       Date:  1971-06       Impact factor: 3.765

5.  Influence of free fatty acid concentration on drug binding to plasma albumin.

Authors:  A A Spector; E C Santos; J D Ashbrook; J E Fletcher
Journal:  Ann N Y Acad Sci       Date:  1973-11-26       Impact factor: 5.691

6.  The binding sites on human serum albumin for some nonsteroidal antiinflammatory drugs.

Authors:  A Kober; I Sjöholm
Journal:  Mol Pharmacol       Date:  1980-11       Impact factor: 4.436

7.  Effects of fatty acids on two specific drug binding sites on human serum albumin.

Authors:  D J Birkett; S P Myers; G Sudlow
Journal:  Mol Pharmacol       Date:  1977-11       Impact factor: 4.436

8.  The displacement of phenylbutazone-14C and warfarin-14C from human albumin by various drugs and fatty acids.

Authors:  H M Solomon; J J Schrogie; D Williams
Journal:  Biochem Pharmacol       Date:  1968-01       Impact factor: 5.858

9.  Intraindividual relationships between serum protein binding of drugs in normal human subjects, patients with impaired renal function, and rats.

Authors:  A Yacobi; G Levy
Journal:  J Pharm Sci       Date:  1977-09       Impact factor: 3.534

10.  Protein binding of tolmetin.

Authors:  M L Selley; B W Madsen; J Thomas
Journal:  Clin Pharmacol Ther       Date:  1978-12       Impact factor: 6.875

View more
  29 in total

Review 1.  Disease-induced variations in plasma protein levels. Implications for drug dosage regimens (Part II).

Authors:  R Zini; P Riant; J Barré; J P Tillement
Journal:  Clin Pharmacokinet       Date:  1990-09       Impact factor: 6.447

Review 2.  Recent findings on the pharmacokinetics of non-steroidal anti-inflammatory drugs in synovial fluid.

Authors:  P Netter; B Bannwarth; M J Royer-Morrot
Journal:  Clin Pharmacokinet       Date:  1989-09       Impact factor: 6.447

3.  Differences in the serum binding determinants of isradipine and darodipine--consequences for serum protein binding in various diseases.

Authors:  J L Pinquier; S Urien; P Chaumet-Riffaud; J P Tillement
Journal:  Br J Clin Pharmacol       Date:  1989-11       Impact factor: 4.335

Review 4.  Drug interactions involving aspirin (acetylsalicylic acid) and salicylic acid.

Authors:  J O Miners
Journal:  Clin Pharmacokinet       Date:  1989-11       Impact factor: 6.447

5.  Articular diffusion of meloxicam after a single oral dose: relationship to cyclo-oxygenase inhibition in synovial cells.

Authors:  F Lapicque; P Vergne; J Y Jouzeau; D Loeuille; P Gillet; E Vignon; P Thomas; P Velicitat; D Türck; C Guillaume; A Gaucher; P Bertin; P Netter
Journal:  Clin Pharmacokinet       Date:  2000-11       Impact factor: 6.447

6.  Hypoalbuminaemia and naproxen pharmacokinetics in a patient with rheumatoid arthritis.

Authors:  F A Van den Ouweland; F W Gribnau; Y Tan; C A Van Ginneken; L B Van de Putte
Journal:  Clin Pharmacokinet       Date:  1986 Nov-Dec       Impact factor: 6.447

Review 7.  Clinical pharmacokinetics of drugs used in juvenile arthritis.

Authors:  K J Skeith; F Jamali
Journal:  Clin Pharmacokinet       Date:  1991-08       Impact factor: 6.447

8.  Lack of relationship between debrisoquine oxidation phenotype and the pharmacokinetics of quinine.

Authors:  S Wanwimolruk; S Chalcroft
Journal:  Br J Clin Pharmacol       Date:  1991-11       Impact factor: 4.335

9.  The binding of ibuprofen to plasma proteins.

Authors:  L Aarons; D M Grennan; M Siddiqui
Journal:  Eur J Clin Pharmacol       Date:  1983       Impact factor: 2.953

Review 10.  Protein binding as a primary determinant of the clinical pharmacokinetic properties of non-steroidal anti-inflammatory drugs.

Authors:  J H Lin; D M Cocchetto; D E Duggan
Journal:  Clin Pharmacokinet       Date:  1987-06       Impact factor: 6.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.